title: Pruritus associated with onabotulinumtoxinA treatment of neuromuscular pain.
abstract: OnabotulinumtoxinA is one of the most widely used agents for cosmetic and medical treatment. Studies have shown that onabotulinumtoxinA is safe and effective with minimal adverse events, and is often well tolerated by patients. We present a patient who developed neuropathic pruritus five days after treatment with onabotulinumtoxinA for neuromuscular pain. This case highlights the treatment of pruritus associated with onabotulinumtoxinA and the therapeutic method to resolve the patient's pruritus.
authors.forename: Derek
authors.initials: D
authors.lastname: Ho
authors.forename: Jared
authors.initials: J
authors.lastname: Jagdeo
mesh_terms: D065087:Acetylcholine Release Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D019274:Botulinum Toxins, Type A / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy; D011537:Pruritus / Q000139:chemically induced* / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D065087:Acetylcholine Release Inhibitors; D019274:Botulinum Toxins, Type A